21427-85-0Relevant academic research and scientific papers
FLUOROALKYL-OXADIAZOLES AND USES THEREOF
-
Paragraph 00608-00609, (2021/06/26)
Provided herein are compounds identified as inhibitors of HDAC6 activity that can be used to treat various diseases and disorders.
FUSED PYRROLIDINE 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5
-
Page/Page column 22, (2009/05/29)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
AMINO 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5
-
Page/Page column 24, (2009/05/29)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
1,2,3-TRIAZOLE PYRROLIDINE DERIVATIVES AS MODULATORS OF MGLUR5
-
Page/Page column 10, (2009/05/29)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
THIOPHENE 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5
-
Page/Page column 20, (2009/05/29)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
MGLUR5 MODULATORS
-
Page/Page column 55, (2008/06/13)
The present invention is directed to compounds of formula (I) Wherein R1 to R5, X and Z are further defined in the description. The invention also relates to processes for the preparation of the compounds and to intermediates used in
MGluR5 modulators V
-
Page/Page column 32, (2008/06/13)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
MGluR5 modulators I
-
Page/Page column 26, (2008/06/13)
The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.
